GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NeoImmuneTech Inc (XKRX:950220) » Definitions » Net Interest Income (for Banks)

NeoImmuneTech (XKRX:950220) Net Interest Income (for Banks)


View and export this data going back to 2021. Start your Free Trial

What is NeoImmuneTech Net Interest Income (for Banks)?

Net Interest Income only applies to banks.


NeoImmuneTech (XKRX:950220) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2400 Research Boulevard, Suite 250, Rockville, MD, USA, 20850
NeoImmuneTech Inc is a clinical-stage T cell-focused biotech company dedicated to the discovery and development of novel immuno-therapeutics. Its lead asset NT-I7 is the clinical stage IL-7, which enhances the body's immune function to address key resistance mechanisms in Immuno-Oncology and deadly infectious diseases.